Marion de Jong

发表

Generation of fluorescently labeled tracers – which features influence the translational potential?

Bart Cornelissen, Fijs W. B. van Leeuwen, Federico Caobelli, 2017, EJNMMI Radiopharmacy and Chemistry.

Developing a tool for the validation of quantitative DCE-MRI

Wiro J. Niessen, Marion de Jong, Jifke F. Veenland, 2011, Medical Imaging.

Multi-modal image registration: matching MRI with histology

Stefan Klein, Wiro J. Niessen, Marion de Jong, 2010, Medical Imaging.

Folate Receptor–Targeted Single-Photon Emission Computed Tomography/Computed Tomography to Detect Activated Macrophages in Atherosclerosis: Can It Distinguish Vulnerable from Stable Atherosclerotic Plaques?

Kim Van der Heiden, Marion de Jong, Jolanda J Wentzel, 2014, Molecular imaging.

SPECT Study of Folate Receptor-Positive Malignant and Normal Tissues in Mice Using a Novel 99mTc-Radiofolate

Marion de Jong, Roger Schibli, F. Forrer, 2008, Journal of Nuclear Medicine.

Low-dose-rate irradiation by 131I versus high-dose-rate external-beam irradiation in the rat pancreatic tumor cell line CA20948.

Marion de Jong, Mark Konijnenberg, B. Bernard, 2004, Cancer biotherapy & radiopharmaceuticals.

Investigation of Particle Accumulation, Chemosensitivity and Thermosensitivity for Effective Solid Tumor Therapy Using Thermosensitive Liposomes and Hyperthermia

Marion de Jong, Holger Grüll, A. Eggermont, 2016, Theranostics.

Folate receptor–targeted single-photon emission computed tomography/computed tomography to detect activated macrophages in atherosclerosis: can it distinguish vulnerable from stable atherosclerotic plaques?

Kim Van der Heiden, Marion de Jong, Jolanda J Wentzel, 2014, Molecular imaging.

Increased physical activity severely induces osteoarthritic changes in knee joints with papain induced sulfate-glycosaminoglycan depleted cartilage

Harrie Weinans, Marion de Jong, Erik de Blois, 2014, Arthritis Research & Therapy.

Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors.

Marion de Jong, R. Valkema, E. Krenning, 2010, Endocrine-related cancer.

Long-term follow-up of renal function after peptide receptor radiation therapy with (90)Y-DOTA(0),Tyr(3)-octreotide and (177)Lu-DOTA(0), Tyr(3)-octreotate.

Marion de Jong, Raffaella Barone, L. Kvols, 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

In Vitro and In Vivo Application of Radiolabeled Gastrin-Releasing Peptide Receptor Ligands in Breast Cancer

Marion de Jong, Erik de Blois, Luc Brunel, 2015, The Journal of Nuclear Medicine.

Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate

Marion de Jong, Mark Konijnenberg, F. Forrer, 2009, European Journal of Nuclear Medicine and Molecular Imaging.

Facilitating Tumor Functional Assessment by Spatially Relating 3D Tumor Histology and In Vivo MRI: Image Registration Approach

Wiro J. Niessen, Lejla Alic, Marion de Jong, 2011, PloS one.

The new era of cancer immunotherapy: what can molecular imaging do to help?

Laura Evangelista, Marion de Jong, Weibo Cai, 2017, Clinical and Translational Imaging.

Radiation dose distribution in human kidneys by octreotides in peptide receptor radionuclide therapy.

Marion de Jong, Mark Konijnenberg, R. Valkema, 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

The role of preclinical SPECT in oncological and neurological research in combination with either CT or MRI

Freek J. Beekman, Roel Van Holen, Marion de Jong, 2014, European Journal of Nuclear Medicine and Molecular Imaging.